CVM
CVM
AMEX · Biotechnology

Cel-Sci Corp

$5.00
+0.10 (+2.04%)
As of Feb 8, 2:20 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 18.47M 17.78M 17.86M
Net Income 823.9K 633.2K 616.7K
EPS
Profit Margin 4.5% 3.6% 3.5%
Rev Growth +3.4% -9.1% -0.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 12.88M 11.76M 14.30M
Total Equity 16.61M 17.78M 17.70M
D/E Ratio 0.78 0.66 0.81
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.32M 1.18M 1.27M
Free Cash Flow 745.4K 469.0K 453.6K